Fibrin targeting of echogenic liposomes with inactivated tissue plasminogen activator

Journal of Liposome Research

Volumn 18, Issue 2, 2008, Pages 95-112

  Klegerman, Melvin E ^a,b   Zou, Yuejiao ^a   Mcpherson, David D ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Fibrin; Liposomes; Plasminogen activator; Targeting; Ultrasound

Indexed keywords

1,2 DIPALMITOYL SN GLYCERO 3 PHOSPHOETHANOLAMINE N [4 (4 MALEIMIDOPHENYL)BUTYRATE]; 1,2 DIPALMITOYL SN GLYCERO 3 PHOSPHOGLYCEROL; ALTEPLASE; CHOLESTEROL; DEXTRO PHENYLALANYLPROLYLARGINYL CHLOROMETHYL KETONE; FIBRIN; IMMUNOGLOBULIN G ANTIBODY; LIPOSOME; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG FORMULATION; ENTHALPY; ENTROPY; ENZYME LINKED IMMUNOSORBENT ASSAY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; THERMODYNAMICS;

AMINO ACID CHLOROMETHYL KETONES; ANIMALS; ANTIBODIES; ANTIBODY AFFINITY; ATHEROSCLEROSIS; CONTRAST MEDIA; DRUG DELIVERY SYSTEMS; ENZYME ACTIVATION; FIBRIN; FIBRINOLYTIC AGENTS; HUMANS; LIPOSOMES; SERINE PROTEINASE INHIBITORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 45749087710     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.1080/08982100802118482     Document Type: Article

References (37)

1. Am. Heart Asso. Statistics Comm. and Stroke Statistics Subcomm. (2007). Heart disease and stroke statistics - 2007 update. Circulation 115:e69-e171.
2. Angles-Cano, E. (1986). A spectrophotometric solid-phase fibrin-tissue plasminogen activator activity assay (SOFIA-tPA) for high-fibrin-affinity tissue plasminogen activators. Anal Biochem 153: 201-210.
3. Blasie, C.A., Berg, J.M. (2002). Structure-based thermodynamic analysis of a coupled metal binding-protein folding reaction involving a zinc finger peptide. Biochemistry 41:15068-15073.
4. Blasie, C.A., Berg, J.M. (2004). Entropy-enthalpy compensation in ionic interactions probed in a zinc finger peptide. Biochemistry 43:10600-10604.
5. Bringmann, P., Gruber, D., Liese, A., Toschi, L., Kratzschmar, J., Schleuning, W.D., Donner, P. (1995). Structural features mediating fibrin selectivity of vampire bat plasminogen activators. J Biol Chem 270:25596-25603.
6. Cheng, X.F., Brohlin, M., Pohl, G. Back, O., Wallen, P. (1995). Binding of tissue plasminogen activator to endothelial cells. Thromb Res 77:149-164.
7. Demos, S.M., Alkan-Onyuksel, H., Kane, B.J., Ramani, K., Nagaraj, A., Green, R., Klegerman, M.E., McPherson, D.D. (1999). In vivo targeting of acoustically reflective liposomes for intravascular and transvascular ultrasonic enhancement. J Am Col Cardiol 33:867-875.
8. Demos, S.M., Dagar, S., Klegerman, M., Nagaraj, A., McPherson, D.D., Onyuksel, H. (1998). In vitro targeting of acoustically reflective liposomes to fibrin under various flow conditions. J Drug Target 5:507-518.
9. Demos, S.M., Onyuksel, H., Gilbert, J., Roth, S.I., Kane, B., Jungblut, P., Pinto, J.V., McPherson, D.D., Klegerman, M.E. (1997). In vitro targeting of Ab-conjugated echogenic liposomes for site-specific ultrasonic image enhancement. J Pharm Sci 86:167-171.
10. Edgell, T., McEvoy, F. Webbon, P., Gaffney, P.J. (1996). Monoclonal antibodies to human fibrin: interaction with other animal fibrins. Thromb Haemost 75:595-599.
11. Eldrup, N., Gronholdt, M.L., Sillesen, H., Nordestgaard, B.G. (2006). Elevated matrix metalloproteinase-9 associated with stroke or cardiovascular death in patients with carotid stenosis. Circulation 114:1847-1854.
12. Flacke, S., Fischer, S., Scott, M.J., Fuhrhop, R.J., Allen J.S., McLean, M., Winter, P., Sicard, G.A., Gaffney, P.J., Wickline, S.A., Lanza, G.M. (2001). Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaques. Circulation 104:1280-1285.
13. Hamilton, A.J., Huang, S.L., Warnick, D., Rabbat, M., Kane, B., Nagaraj, A., Klegerman, M., McPherson, D.D. (2004). Intravascular ultrasound molecular imaging of atheroma components in vivo. J Am Coll Cardiol 43:453-460.
14. Hamilton, A., Huang, S.L., Warnick, D., Stein, A., Rabbat, M., Madhav, T., Kane, B., Nagaraj, A., Klegerman, M., MacDonald, R., McPherson, D. (2002). Left ventricular thrombus enhancement following the intravenous injection of echogenic immunoliposomes: studies in a new experimental model. Circulation 105:2772-2778.
15. Klegerman, M.E., Hamilton, A.J., Huang, S.L., Tiukinhoy, S.D., Khan, A.A., MacDonald, R.C., McPherson, D.D. (2002). Quantitative immunoblot assay for assessment of liposomal antibody conjugation efficiency. Anal Biochem 300:46-52.
16. Klegerman, M.E., Huang, S., Parikh, D., Martinez, J., Demos, S.M., Onyuksel, H.A., McPherson, D.D. (2007). Lipid contribution to the affinity of antigen association with specific antibodies conjugated to liposomes. Biochim Biophys Acta 1768:1703-16.
17. Klegerman, M.E., McPherson, D.D. (2007). Molecular characteristics of inactivated human tissue plasminogen activator association with fibrin implicate the nature and sites of the binding interactions. Arterioscl Thromb Vasc Biol 27:e-108.
18. Koerner, S.K., Kolodziej, A., McMurry, T.J., Nair, S., Nivorozhkin, A.L., Sun, W.C., Wang, X. (2002). Peptide-based multimeric targeted contrast agents. US Patent No 6,991,775.
19. Kolodgie, F.D., Gold, H.K., Burke, A.P., Fowler, D.R., Kruth, H.S., Weber, D.K., Farb, A., Guerrero, L.J., Hayase, M., Kutys, R., Narula, J., Finn, A.V., Virmani, R. (2003). Intraplaque hemorrhage and progression of coronary atheroma. N Eng J Med 349:2316-2325.
20. Lasch, J., Weissig, V., Brandl, M. (2003): Preparation of liposomes. In Torchilin, V.P., Weissig, V. eds. Liposomes, 2nd Ed. New York: Oxford University Press, pp 24-25.
21. Naghavi, M., Libby, P., Falk, E., and 55 other authors. (2003). From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 108:1664-1672.
22. Nesheim, M., Fredenburgh, J.C., Larsen, G.R. (1990). The dissociation constants and stoichiometries of the interactions of lys-plasminogen and chloromethyl ketone derivatives of tissue plasminogen activator and the variant ?FEIX with intact fibrin. J Biol Chem 265:21541-21548.
23. Nieuwenhuizen, W. (1992). Antibodies against fibrin; immunogenic peptides suitable for preparing the antibodies, method for determining fibrin and pharmaceutical preparation based on the antibodies. US Patent No 5,124,439.
24. Ord, J.M., Hasapes, J., Daugherty, A., Thorpe, S.R., Bergmann, S.R., Sobel, B.E. (1992). Imaging of thrombi with tissue-type plasminogen activator rendered enzymatically inactive and conjugated to a residualizing label. Circulation 85:288-297.
25. Ranby, M., Wallen, P. (1981). A sensitive parabolic rate assay for the tissue plasminogen activator. Prog Fibrinol 5:233-235.
26. Raut, S., Gaffney, P. (1996). Evaluation of fibrin binding profile of two antifibrin monoclonal antibodies. Thromb Haemost 76:56-64.
27. Reno, J.M., Hadley, Stephen W., Mohler, M.A. (1993) Method of diagnosing blood clots using fibrin-binding proteins. US Patent No 5,217,705.
28. Rosenthall, L., Leclerc, J. (1995). A new thrombus imaging agent. Human recombinant fibrin binding domain labeled with In-111. Clin Nucl Med 20:398-402.
29. Scopes, R.K. (1982): Protein Purification: Principles and Practice. New York: Springer, pp. 265-266.
30. Sirol, M., Fuster, V. Badimon, J.J., Fallon, J.T., Toussaint, J.F., Fayad, Z.A. (2005). Chronic thrombus detection with in vivo magnetic resonance imaging and a fibrin-targeted contrast agent. Circulation 112:1594-1600.
31. Stracke, C.P., Katoh, M., Wiethoff, A.J., Parsons, E.C., Spangenberg, P., Spuntrup, E. (2007). Molecular MRI of cerebral venous sinus thrombosis using a new fibrin-specific MR contrast agent. Stroke 38:1476-1481.
32. Taillefer, R. (2001). Radiolabeled peptides in the detection of deep venous thrombosis. Semin Nucl Med 31:102-123.
33. Tiukinhoy-Laing, S.D., Buchanan, K., Parikh, D., Huang, S., MacDonald, R.C., McPherson, D.D., Klegerman, M.E. (2007). Fibrin targeting of tissue plasminogen activator-loaded echogenic liposomes. J Drug Target 15:109-114.
34. Torchilin, V.P., Weissig, V., Martin, F.J., Heath, T.D., New, R.R.C. (2003): Surface modification of liposomes. In Torchilin, V.P., Weissig, V., eds. Liposomes, 2nd Ed. New York: Oxford University Press, pp. 193-229.
35. Tsurupa, G., Medved, L. (2001). Fibrinogen αC Domains Contain Cryptic Plasminogen and tPA Binding Sites. Ann NY Acad Sci 936: 328-330.
36. Verheijen, J.H., Caspers, M.P.M., Chang, G.T.G., de Munk, G.A.W., Pouwels, P.H., Enger-Valk, B.E. (1986). Involvement of finger domain and kringle 2 domain of tissue-type plasminogen activator in fibrin binding and stimulation of activity by fibrin. EMBO J 5:3525-3530.
37. Yonekawa, O., Voskuilen, M., Nieuwenhuizen, W. (1992). Localization in the fibrinogen gamma-chain of a new site that is involved in the acceleration of the tissue-type plasminogen activator-catalysed activation of plasminogen. Biochem J 283:187-191.